Heron Therapeutics

$17.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (+1.87%) As of 8:26 PM UTC today

Why Robinhood?

You can buy or sell HRTX and other stocks, options, and ETFs commission-free!

About HRTX

Heron Therapeutics, Inc. Common Stock, also called Heron Therapeutics, is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA. The listed name for HRTX is Heron Therapeutics, Inc. Common Stock.

CEO

Barry D. Quart

Employees

231

Headquarters

San Diego, California

Founded

1983

Market Cap

1.68B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.03M

High Today

$18.08

Low Today

$17.64

Open Price

$17.97

Volume

741.18K

52 Week High

$24.76

52 Week Low

$9.60

Collections

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

HRTX Earnings

-$0.65

-$0.43

-$0.22

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 1, Pre-Market